MELE, Teresa
MELE, Teresa
Mostra
records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.009 secondi).
Chapter 17, Achievements in Targeted Therapies - ERS Monographs - Lung Cancer
2015-01-01 Bironzo Paolo; Mele Teresa; Novello Silvia
Extending survival of stage IV non-small cell lung cancer.
2014-01-01 Carnio S;Novello S;Mele T; Giaj Levra Matteo; Scagliotti GV
Intermediate endpoints of primary systemic therapy in breast cancer patients.
2011-01-01 Berruti A; Generali D; Bertaglia V; Brizzi MP; Mele T; Dogliotti L; Bruzzi P; Bottini A.
Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.
2017-01-01 Vavalà, T; Monica, V; Lo Iacono, M; Mele, T; Busso, S; Righi, L; Papotti, M; Scagliotti, Gv; Novello, S
The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
2011-01-01 Fox SB; Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Bersiga A; Allevi G; Milani M; Aguggini S; Mele T; Dogliotti L; Bottini A; Harris AL.
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells.
2014-01-01 Rondón-Lagos M;Verdun Di Cantogno L;Rangel N;Mele T;Ramírez-Clavijo SR;Scagliotti G;Marchiò C;Sapino A